Biodexa Pharmaceuticals Plc (BDRX) stock
BDRXNasdaqPharmaceutical PreparationsFiscal year ends December 31
$2.04−0.10 (-4.89%)
Close on Nov 18, 2026Market cap $4.60MP/E –Yield –
Biodexa Pharmaceuticals gross profit
Gross profit is revenue minus the direct cost of the goods and services sold.
For fiscal 2017 it was £6.67M, up 6.6% from the year before.
Annual gross profit
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2017 | Dec 31, 2017 | £6.67M | +6.6% |
| FY2016 | Dec 31, 2016 | £6.26M | +379.4% |
| FY2015 | Dec 31, 2015 | £1.31M | – |
See a number that looks wrong?